- Home
- SIRI vs JAZZ Comparison
SIRI vs JAZZ Comparison
Compare SIRI & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIRI
- JAZZ
- Stock Information
- Founded
- SIRI 2013
- JAZZ 2003
- Country
- SIRI United States
- JAZZ Ireland
- Employees
- SIRI N/A
- JAZZ N/A
- Industry
- SIRI Broadcasting
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- SIRI Consumer Discretionary
- JAZZ Health Care
- Exchange
- SIRI Nasdaq
- JAZZ Nasdaq
- Market Cap
- SIRI 8.8B
- JAZZ 7.3B
- IPO Year
- SIRI 1994
- JAZZ 2007
- Fundamental
- Price
- SIRI $22.27
- JAZZ $121.18
- Analyst Decision
- SIRI Hold
- JAZZ Buy
- Analyst Count
- SIRI 14
- JAZZ 14
- Target Price
- SIRI $27.58
- JAZZ $173.93
- AVG Volume (30 Days)
- SIRI 5.8M
- JAZZ 567.6K
- Earning Date
- SIRI 01-30-2025
- JAZZ 02-26-2025
- Dividend Yield
- SIRI 4.85%
- JAZZ N/A
- EPS Growth
- SIRI N/A
- JAZZ 458.10
- EPS
- SIRI N/A
- JAZZ 7.04
- Revenue
- SIRI $8,799,000,000.00
- JAZZ $3,992,712,000.00
- Revenue This Year
- SIRI N/A
- JAZZ $7.51
- Revenue Next Year
- SIRI N/A
- JAZZ $6.84
- P/E Ratio
- SIRI N/A
- JAZZ $17.22
- Revenue Growth
- SIRI N/A
- JAZZ 5.23
- 52 Week Low
- SIRI $20.47
- JAZZ $99.06
- 52 Week High
- SIRI $55.40
- JAZZ $134.17
- Technical
- Relative Strength Index (RSI)
- SIRI 45.13
- JAZZ 46.66
- Support Level
- SIRI $21.40
- JAZZ $118.72
- Resistance Level
- SIRI $22.10
- JAZZ $124.66
- Average True Range (ATR)
- SIRI 0.66
- JAZZ 2.82
- MACD
- SIRI 0.09
- JAZZ -0.21
- Stochastic Oscillator
- SIRI 55.05
- JAZZ 31.62
About SIRI Sirius XM Holdings Inc.
Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service, which offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company operates the service through a handful of geostationary satellites that it owns and operates, but it now offers a streaming SiriusXM option as well. Pandora, which makes up a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants like Spotify, Apple Music, and YouTube Music.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.